ABRAXANE For Metastatic Breast Cancer Approved In Australia (Medical News Today)
Abraxis BioScience, Inc.

FDA Approves Astepro - Nasal Antihistamine In The Treatment Of Rhinitis (Medical News Today)
The U.S. Food and Drug Administration (FDA) has approved Astepro - the new formulation of Astelin. Astepro Nasal Spray is an improvement over the marketed Astelin Nasal Spray and is better tolerated by patients using the new spray. The active substance in these products is azelastine - the leading nasal antihistamine in the treatment of rhinitis in the U.S.